How This Dutch AI Startup Is Quietly Reshaping Hearing Healthcare

Jan de Vries · 2026-08-28

Here's something interesting from across the pond. There's a startup in Maastricht, Netherlands, that's just secured a significant seed round to tackle a problem you might not think about every day, but it affects billions. They're using AI not just as a buzzword, but as a genuine bridge to care. Clementine, also known as ClementineAI, has raised $2 million in seed funding. That's a solid vote of confidence for a company founded just this year. The round was led by Healthy.Capital, an Amsterdam-based early-stage investor with a sharp eye for promising HealthTech. ### The Core Problem Clementine Is Solving Let's talk about the scale of this for a second. According to their data, hearing loss impacts about 1.5 billion people globally. That's a staggering number. But here's the real kicker: nearly 80% of those people never actually seek treatment. And for those who finally do? They typically wait over eight years. Eight years! That's a long time to live with a diminishing quality of life. The founder and CEO, Vince van de Weijer, puts it bluntly: "Clinics don't need more leads; they need better conversations at the right moment." It's a classic case of a funnel bottleneck. Getting someone's attention is one thing, but guiding them through the fear, confusion, and administrative hurdles to actually book an appointment is another beast entirely. ### Meet Matthew: The AI Agent Making The Difference So, what's their solution? It's built around a character named Matthew. No, not a person—Matthew is Clementine's AI hearing care agent. Think of him as a compassionate, infinitely patient guide who's available 24/7. Here’s what Matthew does that's so different: - Answers questions anytime, without judgment or a waiting list - Educates potential patients in a low-pressure way - Helps overcome the emotional and practical barriers that stop people from seeking help - Gently guides them toward the appropriate next steps for care For clinics, this isn't just a fancy chatbot. It translates directly into reduced administrative burden for staff and turns more inquiries into actual bookings. For patients, it means a streamlined, less intimidating path to better hearing outcomes. ### Why Investors Are Betting On This Approach Douwe Jippes, managing partner at Healthy.Capital, highlighted the combination of "deep domain expertise with a clear AI platform strategy that can scale globally." He believes this approach can fundamentally change how people with hearing disabilities engage with healthcare. That's the kind of impact investors love to back. It's not just theory, either. The funding follows closely on the heels of a key commercial move: a partnership with Zoolstra, a marketing agency that works with hearing clinics and groups across the United States and Canada. This gives Clementine a direct pipeline to the massive North American market. ### What's Next For Clementine? The fresh capital has a clear purpose. The team plans to deepen their AI's capabilities and aggressively expand partnerships. They're looking beyond just hearing clinics to optical retailers and other healthcare organizations. The vision is to create a judgment-free, always-available starting point for hearing care long before someone walks into a physical clinic. By pairing AI with behavioral science, Clementine is addressing the gap between knowing you need help and actually getting it. In a world where we automate everything else, using technology to automate empathy and access in healthcare might just be the next big thing. It's a Dutch startup to watch, showing how focused AI application can solve very human problems.